Precision Vaccinations (PVax) is an international publisher of information people can trust to make informed vaccination decisions. PVax's goal is to publish vaccine-centric information that enables people to live life to the fullest!
Known as the 'Worldwide Wiki for Vaccines,' PVax's science-based, fact-checked vaccine library is continually enhanced with breaking news to facilitate main-street conversations regarding which vaccine is best for each person's DNA.
Furthermore, PVax research-based, global information increases clinical trial result transparency, reveals innovative cell-based science, and is vetted for commercial bias.
PVax's vaccine library integrates information from the European Medicines Agency, the World Health Organization, the UK, India, China, Brazil, Australia, and other international regulatory agencies.
Recently, the World Health Organization said, 'vaccine misinformation is a major threat to global health that could reverse decades of progress in tackling preventable diseases. Digital organizations have a responsibility to their users.... to ensure that they can access facts about vaccines.'
We have been 'fact-checking' vaccine information for years and believe publishers must earn readers' trust ....every day!
In December 2021, PVax launched the first patient-centric vaccine rating app. This original data will guide future content editing, publishing, and syndication strategies.
Empower consumers, doctors, nurses, and pharmacists with trustworthy information to maximize each person's immunization needs to reduce overall healthcare costs.
Superior Content Management System
PVax's proprietary content management system empowers the company's 3rd generation multi-brand, innovative, producer-controlled syndication of mobile-user-centric user experiences while achieving low-cost publisher advantages. In addition, the CHAD 3.2 digital environment maximizes AI utility throughout PVax's content creation and distribution network.
- Trusted - only licensed providers edit our content, delivering 100% transparency
- Understandable - our clinical information is written with a positive voice, translated into "main street" conversation
- Breaking research is contextually integrated into the news as it is published;
- Experience - each article is designed with uniform navigation, offering a consistent learning experience
Did You Know
- 93% of patients read online news
- 82% of adults surveyed said they seek out trustworthy news
- 39% of people trust information from providers
- 37% of seniors now get vaccinations from pharmacies
- 22% of press releases exaggerate causal claims from correlational findings in observational studies.
Vaccine Market Overview
Life-saving vaccines have had a profound impact on the world. Globally, 2 to 3 million fewer deaths occur yearly because people are vaccinated and protected from diseases. Today, almost anyone can receive immunizations against seventeen once common and potentially deadly infectious diseases in the United States.
Since the Human Genome Project's success in 2000, people are gaining awareness that their genetic makeup can impact the quality of life. Soon, the promise of personalized vaccines will become a reality, disrupting the one-size-fits-all vaccination model.
According to the CDC, almost 3.5 billion vaccine doses have been distributed in the United States over the past ten years. And research says that for every $1 spent on vaccines, $3 indirect benefits are realized from an economic perspective.
PV publishes breaking news posts, featured news articles, disease information channels, and an extensive vaccine library. These pages are reviewed for relevance and accuracy daily.
PV supports these industry-leading non-profit, health news publishing criteria:
Would you like to share our vaccination news articles from your website or mobile app? Choose the RSS to feed the Latest News: https://www.precisionvaccinations.com/rss/short/media
Inclusiveness is at the heart of thinking and acting as journalists. The complex issues we face as a society require respect for different viewpoints. Race, class, generation, gender, and geography affect perspective. Reflecting these differences in our reporting leads to better, more nuanced stories and a better-informed community. Therefore, we seek diverse voices in our management and reporting staff.
Precision Vax publishes vaccine information based upon valid research from universities, government agencies, pharmaceutical manufacturers, and the WHO. Furthermore, these organizations' editorial biases do not influence PV's independently published content. PV cites potential conflicts of interest on the same page as the published, relevant work.
PV's digital newsroom is insulated from any interaction with advertisers.
And our news-gathering team is independent of commercial or political interests. We do not accept gifts or any remuneration to avoid any conflict of interest. Additionally, we do not allow third parties to "ghost-write" news articles. If you have any questions, contact [email protected].
Medical Advisory Team
The Medical Advisory Team works closely with pharmacists, doctors, and nurses across various specialty areas to ensure PrecisionVax's published content is accurate, actionable, and understandable. If you have any questions, please contact Dr. Robert Carlson, [email protected].
Our news team has been fact-checking health news for over 20 years and commits to doing its best to publish accurate information. We stand by the information we publish, and if it's not correct, we will change it as quickly as possible. In addition, we take many steps to ensure accuracy, such as:
- We investigate claims with skepticism; question assumptions; challenge conventional wisdom;
- We confirm information with subject-matter experts and seek to corroborate what sources tell us by talking with other informed people or consulting documents;
- We verify content, such as technical terms, stats, etc., against source documents or clarify who provides the information. For example, we may share relevant components of a story with a primary source or an outside expert to verify them.
Various PVax policies are listed on this webpage.
Precision Vax, LLC is a 100% woman-owned private enterprise founded in 2016. Karen McClorey Hackett, Precision Vax's president, is committed to transparency in our ownership structure and revenue sources. Karen launched her career with IBM and has been investing in digital health enterprises since 1997. Here is Karen's Linkedin profile.
We primarily produce our revenues from advertising. Our dominant digital advertiser is Google Adsense. As such, our editorial team has no relationship, nor communications, with any advertiser. Google Ads Terms & Conditions are published at this link.
PVax also has lead generation business agreements for clinical trials, diagnostic tests, and vaccine appointment requests.
Comments and Concerns
We believe that public feedback is not a one-way street. Instead, we are committed to engaging with you and taking action based on your suggestions and other feedback. In line with this, we are committed to providing greater transparency about how news is produced and offering regular contact and interaction points. In addition, we believe that news organizations have a responsibility to engage with the public on the values, issues, and ideas of the day and gain much to gain in return.
We will respond to your request within two business days. Would you mind sending an email to [email protected]?
Karen Hackett, Found & President